Neuberg Bose Laboratories Private Limited, a active private limited company, was established on 28 December 2021 in Madurai, Tamil Nadu, India. Engaging in consumer professional services within the hospital and medical care sector, it holds CIN: U24299TN2021PTC148870. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.79 M.
Its leadership includes Athmanathan Ganesan (Director), Kavya K Velu (Director), Sivam Puratchimani Arivarasan (Whole-Time Director). Past directors included Athmanathan Ganesan, Kavya K Velu, Vadakanchary Bharatha Gopal Krishnan. It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at 57 B/ 1 Tamil Sangam Main Road Tamil Sangam Road,, Madurai, Tamil Nadu, 625020.
U24299TN2021PTC148870
148870
28 December 2021
₹3.00 M
₹1.79 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Neuberg Bose Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Athmanathan Ganesan | Director | 12 May 2022 | Current |
| Kavya K Velu | Director | 14 May 2024 | Current |
| Sivam Puratchimani Arivarasan | Whole-Time Director | 28 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 12 May 2022 | Past |
| Pramod Abcsdd | Additional Director | 14 May 2024 | Past |
| Pramod Abcsdd | Additional Director | 12 May 2022 | Past |
| Pramod Abcsdd | Director | 12 May 2022 | Past |
| Pramod Abcsdd | Director | 12 Apr 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neuberg Bose Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 12050% decrease in profit. The company's net worth Soared by an impressive increase of 75094.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Neuberg Bose Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2023 | Hdfc Bank Limited | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Neuberg Bose Laboratories has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Neuberg Bose Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuberg Bose Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Neuberg Bose Laboratories Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was completed.
The activity Neuberg Bose Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.
Kavya K Velu was appointed as a Director was appointed as a Director on 14 May 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 50.00 M with Charge ID 100773737 was registered on 14 Aug 2023. was completed.
The activity Athmanathan Ganesan was appointed as a Director was appointed as a Director on 12 May 2022 & has been associated with this company since 3 years 8 months . was completed.
The activity Sivam Puratchimani Arivarasan was appointed as a CEO was appointed as a CEO on 12 Apr 2022 & has been associated with this company since 3 years 9 months . was completed.
The CIN of Neuberg Bose Laboratories Private Limited is U24299TN2021PTC148870.
Neuberg Bose Laboratories Private Limited is headquartered at 57 B/ 1 Tamil Sangam Main Road Tamil Sangam Road,, Madurai, Tamil Nadu, 625020.
Neuberg Bose Laboratories Private Limited was incorporated on 28 December 2021.
The current directors of Neuberg Bose Laboratories Private Limited are
The primary industry of Neuberg Bose Laboratories Private Limited is Hospital And Medical Care.
Neuberg Bose Laboratories Private Limited is unlisted.
The authorized capital of Neuberg Bose Laboratories Private Limited is ₹3.00 M, and the paid-up capital is ₹1.79 M.
Search company & director profiles for free and gain access to critical business data.
_303771.webp)
Company Details
+91-XXXXXXXXXX